<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Arq Bras Cardiol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Arq. Bras. Cardiol</journal-id>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26577721</article-id>
      <article-id pub-id-type="pmc">4651413</article-id>
      <article-id pub-id-type="doi">10.5935/abc.20150047</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Coronary Fistulas in a Patient with a Novel Long QT Syndrome
Mutation</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Pl&#xE1;cido</surname>
            <given-names>Rui</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
          <xref ref-type="corresp" rid="c01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cortez-Dias</surname>
            <given-names>Nuno</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Veiga</surname>
            <given-names>Arminda</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jorge</surname>
            <given-names>Cl&#xE1;udia</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Miltenberger-Milt&#xE9;ny</surname>
            <given-names>G&#xE1;briel</given-names>
          </name>
          <xref ref-type="aff" rid="aff02">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pinto</surname>
            <given-names>Fausto</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
      </contrib-group>
      <aff id="aff01"><label>1</label>Departamento de Cardiologia, Hospital Santa Maria
University, Lisbon Academic Medical Centre, CCUL, Lisbon &#x2013; Portugal</aff>
      <aff id="aff02"><label>2</label>Instituto de Medicina Molecular, Lisbon University Medical
School, University of Lisbon, Lisbon &#x2013; Portugal</aff>
      <author-notes>
        <corresp id="c01"><bold>Mailing Address: Rui Miguel Freire Pl&#xE1;cido</bold>, Hospital de
Santa Maria &#x2013; Servi&#xE7;o de Cardiologia. Avenida Professor Egas Moniz Postal Code
1600-190 - Lisboa &#x2013; Portugal E-mail: <email>placidorui@gmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <month>11</month>
        <year>2015</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <month>11</month>
        <year>2015</year>
      </pub-date>
      <volume>105</volume>
      <issue>5</issue>
      <fpage>536</fpage>
      <lpage>539</lpage>
      <history>
        <date date-type="received">
          <day>12</day>
          <month>1</month>
          <year>2015</year>
        </date>
        <date date-type="rev-recd">
          <day>26</day>
          <month>2</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>26</day>
          <month>2</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution License, which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly
cited.</license-p>
        </license>
      </permissions>
      <kwd-group>
        <kwd>Long QT Syndrome</kwd>
        <kwd>Channelopathies</kwd>
        <kwd>Torsades de Pointes</kwd>
        <kwd>Coronary Vessel Anomalies</kwd>
        <kwd>Arteriovenous Fistula</kwd>
        <kwd>Tachycardia, Ventricular</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>Introduction</title>
      <p>The congenital long QT syndrome (LQTS) is a genetic cardiac channelophathy with variable
penetrance characterized by corrected QT (QTc) interval prolongation and predisposition
to polymorphic ventricular tachycardia (PVT), which normally presents with syncope or
sudden death. It can be caused by mutations in different ion channels, resulting in
prolongation of the myocardial repolarization<sup><xref rid="r01" ref-type="bibr">1</xref></sup>. The clinical course of LQTS throughout a patient&#x2019;s lifetime is
significantly influenced by the genotype and acquired factors that additionally
compromise myocardial repolarization, including drug use, serum electrolyte
abnormalities, autoimmune diseases, severe bradycardia, acute heart failure
decompensation and myocardial ischemia<sup><xref rid="r02" ref-type="bibr">2</xref></sup>.</p>
      <p>This report presents the first description of PVT precipitated by myocardial ischemia
secondary to multiple coronary fistulas in a patient with a novel LQTS-causing
mutation.</p>
    </sec>
    <sec>
      <title>Case Report</title>
      <p>A 47-year-old woman presented at the emergency department due to recurrent syncope
within the last 2 days. Episodes occurred during moderate to extenuating exertion and
were preceded by short-duration chest pain. She was a heavy smoker but no other
cardiovascular risk factors were identified. During adolescence, she had been treated
with phenytoin for two years for what was thought to be a seizure disorder. Since then,
no further episodes of loss of consciousness had occurred and she was not receiving any
medication. There was no family history of sudden death. Physical exam, chest X-ray and
cranial computed tomography were unremarkable. Initial 12-lead ECG during sinus rhythm
showed a marked QTc interval prolongation (640 ms) with T-wave inversion in the
precordial, lateral and inferior leads (<xref ref-type="fig" rid="f01">Figure 1</xref>,
panel A). In addition, frequent episodes of nonsustained PVT were documented (<xref ref-type="fig" rid="f01">Figure 1</xref> &#x2013; panel B). Echocardiography revealed
anterior apical hypokinesia with preserved global ejection fraction. Complete blood
count, serum electrolytes, renal function parameters, glycemia and thyroid hormones were
normal. Troponin I was mildly elevated (0.59 ng/mL; reference range, &lt; 0.07 ng/mL).
A&#xA0;diagnosis of LQTS was assumed and the patient was treated with magnesium sulphate and
beta-blocker, becoming asymptomatic and event-free. Coronary angiography showed no
significant coronary stenosis, but fistulas from the diagonal arteries to the left
ventricle cavity (<xref ref-type="fig" rid="f02">Figure 2</xref>) were found. To assess
the functional significance of these coronary abnormalities, the patient underwent 99mTc
tetrofosmin myocardial perfusion imaging that showed at rest and under stress lower
apical activity and a small area of lower radiotracer uptake in the apical segment of
the anterior wall, reversible at rest. Direct sequencing of the <italic>KCNH2,
KCNQ1</italic> and <italic>SCN5A</italic> genes revealed a novel heterozygous
frameshift mutation in the sixth exon of the <italic>KCNH2</italic> gene producing a
premature STOP codon: c.1232_1234delinsTTTGAA (p.Asp411Valfs*2). No pathogenic
alterations were found in the other two genes. The patient was discharged with
propranolol 100 mg/day, with close outpatient follow-up and plan for genetic
counseling.</p>
      <fig id="f01" orientation="portrait" position="float">
        <label>Figure 1</label>
        <caption>
          <p>Admission electrocardiogram showing prolongation of the QTc interval (panel A) and
multiples episodes of nonsustained polymorphic ventricular tachycardia (panel
B).</p>
        </caption>
        <graphic xlink:href="abc-105-05-0536-g01"/>
      </fig>
      <fig id="f02" orientation="portrait" position="float">
        <label>Figure 2</label>
        <caption>
          <p>Right caudal coronariography view showing small fistulas involving the diagonal
arteries (arrows).</p>
        </caption>
        <graphic xlink:href="abc-105-05-0536-g02"/>
      </fig>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>Several factors have been shown to enhance variability and prolong myocardial
repolarization, predisposing to ventricular arrhythmias. In the LQTS it is possible to
describe a continuous spectrum of risk for cardiac events, based on a combination of
causes that prolong action potential duration and QT interval, reducing the
repolarization reserve<sup><xref rid="r03" ref-type="bibr">3</xref></sup>. Responses to
QT-prolonging factors differ among individuals. This variability in response to acquired
factors is paralleled by variability in the extent to which a given mutation in the
congenital LQTS prolongs QT interval and causes arrhythmias.</p>
      <p>In the present case, we reported an unusual association between two rare cardiac
conditions: the phenotypic manifestation of congenital LQTS was precipitated by
myocardial ischemia secondary to coronary fistulas, based on clinical and
pathophysiological criteria.</p>
      <p>It is known that both myocardial ischemia and LQTS contribute to ventricular
tachyarrhythmias that can cause sudden cardiac death. Although the arrhythmogenicity of
myocardial ischemia and LQTS have been well documented, the effects of myocardial
ischemia in the setting of LQTS are unclear. Several studies have suggested that both QT
interval and QT dispersion, an index of the spatial inhomogeneity of the ventricular
recovery times, are prolonged by ischemia<sup><xref rid="r04" ref-type="bibr">4</xref></sup>. Furthermore, LQTS is frequently associated with increased QT
dispersion. An increased QT dispersion theoretically provides a substrate for functional
reentry and has been associated with an increased incidence of malignant ventricular
arrhythmias and sudden death<sup><xref rid="r05" ref-type="bibr">5</xref>,<xref rid="r06" ref-type="bibr">6</xref></sup>.</p>
      <p>In our patient, the multiple coronary artery fistulas caused myocardial ischemia as
documented by the myocardial scintigraphy. The presence of coronary fistulas is
uncommon, with a reported incidence of 0.1% to 0.2% in patients undergoing coronary
angiography. They can occur from any of the three major coronary arteries, but the
majority arises from the right coronary or the left anterior descending arteries. Over
90% of the fistulas drain into the venous circulation. Complications include congestive
heart failure due to a left-to-right cardiac shunt, myocardial ischemia, rupture of
aneurysmal fistulas and endocarditis. Arrhythmias related to coronary artery fistulas
are extremely rare and include ventricular tachycardia, sinus-node dysfunction and
atrial fibrillation. The mechanisms are not completely understood and are probably
ischemia-related<sup><xref rid="r07" ref-type="bibr">7</xref></sup>. The
management of coronary fistulas is still controversial and recommendations are based on
small retrospective series. The main indications for surgical or percutaneous closure
with coils are clinical symptoms, especially of heart failure and myocardial ischemia.
In our case, correction of fistulas was discouraged due to their high number and small
diameter. Furthermore, beta-blocker therapy was effective in controlling ischemic
symptoms and arrhythmic manifestations.</p>
      <p>This case has another particularity, as it describes a type 2-LQTS due to a new mutation
(p.Asp411Valfs*2) in the <italic>KCNH2</italic> (<italic>HERG</italic>) gene. Although
this alteration is novel, pathogenicity is highly probable: the mutation leads to a
frameshift and a premature termination codon two amino acids after the affected aspartic
acid. We analyzed this novel alteration for pathogenicity with Mutation Taster
(<ext-link ext-link-type="uri" xlink:href="http://www.mutationtaster.org">www.mutationtaster.org</ext-link>), an in-silico program that predicts the disease
potential of genetic alterations. This analysis classified the p.Asp411Valfs*2 mutation
as disease causing. The position p.Asp411, which is localized in the first transmembrane
domain (S1) of HERG, has a special role in the protein, as it is one of the six negative
charges in the voltage-sensing domain<sup><xref rid="r08" ref-type="bibr">8</xref></sup>. Also, p.Asp411 is creating a functional coupling with p.Lys538, at the
inner end of the S4 transmembrane domain. Previous studies by Liu et al.<sup>11</sup> on
the function of this codon showed that in-vitro mutagenesis (p.Asp411Cys) resulting in
protonation of this aspartate contributes to the signaling pathway, whereby external
[H+] influences conformational changes in the channel&#xB4;s cytoplasmic domains. The Asp to
Val change, as seen in our patient, also leads to protonation of this aspartic acid,
further supporting the pathogenicity of the novel p.Asp411Valfs*2 alteration.</p>
      <p>LQT2 is the second most common genotype of LQTS, and occurs in 35&#x2013;45% of genotyped
patients with LQTS<sup><xref rid="r09" ref-type="bibr">9</xref></sup>. It has been shown
that the clinical course of LQTS throughout an affected patient&#x2019;s lifetime is influenced
by genotype and genetic testing for the common subtypes of the LQTS can identify a
mutation in 50 to 75% of probands in whom the diagnosis appears to be certain on
clinical grounds. Risk stratification based on genetics is encouraged in some cases,
probably having therapeutic implications. For example, previous observations by Moss et
al.<sup><xref rid="r10" ref-type="bibr">10</xref></sup> found that LQTS type 1 and
LQT2 patients benefited significantly from beta-blocker therapy. Also, in a family with
an affected proband and a known genetic defect, the genotyping of family members can
help rule out the diagnosis.</p>
      <p>In conclusion, to our knowledge this is the first description of the association between
LQTS and multiple coronary fistulas, two rare cardiac conditions as far as we know
without causal association in their primary origin. Recurrent episodes of ischemia
secondary to the multiple coronary fistulas may have played an important role as
precipitating factors on the genesis of PVT in this patient with a novel LQTS-causing
mutation.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="con">
        <p>
<bold>Author contributions</bold>
</p>
        <p>Acquisition of data:Pl&#xE1;cido RMF. Writing of the manuscript:Pl&#xE1;cido RMF. Critical
revision of the manuscript for intellectual content: Pl&#xE1;cido RMF, Cortez-Dias N,
Veiga A, Jorge C, Miltenberger-Milt&#xE9;ny G, Pinto F.</p>
      </fn>
      <fn fn-type="conflict">
        <p>
<bold>Potential Conflict of Interest</bold>
</p>
        <p>No potential conflict of interest relevant to this article was reported.</p>
      </fn>
      <fn fn-type="supported-by">
        <p>
<bold>Sources of Funding</bold>
</p>
        <p>There were no external funding sources for this study.</p>
      </fn>
      <fn fn-type="other">
        <p>
<bold>Study Association</bold>
</p>
        <p>This study is not associated with any thesis or dissertation work.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="r01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Morita</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Zipes</surname>
              <given-names>DP</given-names>
            </name>
          </person-group>
          <article-title>The QT syndromes: long and short</article-title>
          <source>Lancet</source>
          <year>2008</year>
          <volume>372</volume>
          <issue>9640</issue>
          <fpage>750</fpage>
          <lpage>763</lpage>
          <pub-id pub-id-type="pmid">18761222</pub-id>
        </element-citation>
      </ref>
      <ref id="r02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Emori</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Antzelevitch</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Cellular basis for complex T waves and arrhythmic activity following
combined I(Kr) and I(Ks) block</article-title>
          <source>J Cardiovasc Electrophysiol</source>
          <year>2001</year>
          <volume>12</volume>
          <issue>12</issue>
          <fpage>1369</fpage>
          <lpage>1378</lpage>
          <pub-id pub-id-type="pmid">11797994</pub-id>
        </element-citation>
      </ref>
      <ref id="r03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Roden</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Abraham</surname>
              <given-names>RL</given-names>
            </name>
          </person-group>
          <article-title>Refining repolarization reserve</article-title>
          <source>Heart Rhythm</source>
          <year>2011</year>
          <volume>8</volume>
          <issue>11</issue>
          <fpage>1756</fpage>
          <lpage>1757</lpage>
          <pub-id pub-id-type="pmid">21708111</pub-id>
        </element-citation>
      </ref>
      <ref id="r04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chauhan</surname>
              <given-names>VS</given-names>
            </name>
            <name>
              <surname>Tang</surname>
              <given-names>AS</given-names>
            </name>
          </person-group>
          <article-title>Dynamic changes of QT interval and QT dispersion in non-Q-wave and
Q-wave myocardial infarction</article-title>
          <source>J Electrocardiol</source>
          <year>2001</year>
          <volume>34</volume>
          <issue>2</issue>
          <fpage>109</fpage>
          <lpage>117</lpage>
          <pub-id pub-id-type="pmid">11320458</pub-id>
        </element-citation>
      </ref>
      <ref id="r05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Barr</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Naas</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Freeman</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lang</surname>
              <given-names>CC</given-names>
            </name>
            <name>
              <surname>Struthers</surname>
              <given-names>AD</given-names>
            </name>
          </person-group>
          <article-title>QT dispersion and sudden unexpected death in chronic heart
failure</article-title>
          <source>Lancet</source>
          <year>1994</year>
          <volume>343</volume>
          <issue>8893</issue>
          <fpage>327</fpage>
          <lpage>329</lpage>
          <pub-id pub-id-type="pmid">7905146</pub-id>
        </element-citation>
      </ref>
      <ref id="r06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zareba</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Moss</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Le Cessie</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Dispersion of ventricular repolarization and arrhythmic cardiac death
in coronary artery disease</article-title>
          <source>Am J Cardiol</source>
          <year>1994</year>
          <volume>174</volume>
          <issue>6</issue>
          <fpage>550</fpage>
          <lpage>553</lpage>
          <pub-id pub-id-type="pmid">8074036</pub-id>
        </element-citation>
      </ref>
      <ref id="r07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gowda</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Vasavada</surname>
              <given-names>BC</given-names>
            </name>
            <name>
              <surname>Khan</surname>
              <given-names>IA</given-names>
            </name>
          </person-group>
          <article-title>Coronary artery fistulas: clinical and therapeutic
considerations</article-title>
          <source>Int J Cardiol</source>
          <year>2006</year>
          <volume>107</volume>
          <issue>1</issue>
          <fpage>7</fpage>
          <lpage>10</lpage>
          <pub-id pub-id-type="pmid">16125261</pub-id>
        </element-citation>
      </ref>
      <ref id="r08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Jiang</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tseng</surname>
              <given-names>GN</given-names>
            </name>
          </person-group>
          <article-title>Negative charges in the transmembrane domains of the HERG K channel
are involved in the activation- and deactivation-gating processes</article-title>
          <source>J Gen Physiol</source>
          <year>2003</year>
          <volume>121</volume>
          <issue>6</issue>
          <fpage>599</fpage>
          <lpage>614</lpage>
          <pub-id pub-id-type="pmid">12771194</pub-id>
        </element-citation>
      </ref>
      <ref id="r09">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Splawski</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Shen</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Timothy</surname>
              <given-names>KW</given-names>
            </name>
            <name>
              <surname>Lehmann</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Priori</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Robinson</surname>
              <given-names>JL</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A,
KCNE1, and KCNE2</article-title>
          <source>Circulation</source>
          <year>2000</year>
          <volume>102</volume>
          <issue>10</issue>
          <fpage>1178</fpage>
          <lpage>1185</lpage>
          <pub-id pub-id-type="pmid">10973849</pub-id>
        </element-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Moss</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Zareba</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Hall</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Schwartz</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Crampton</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Benhorin</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Effectiveness and limitations of beta-blocker therapy in congenital
long QT syndrome</article-title>
          <source>Circulation</source>
          <year>2000</year>
          <volume>101</volume>
          <fpage>616</fpage>
          <lpage>623</lpage>
          <pub-id pub-id-type="pmid">10673253</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
